Lewy bodies are made primarily of a misfolded protein called alpha-synuclein, which clumps into dense, tangled fibers inside nerve cells. About 90% of the alpha-synuclein found in Lewy bodies carries a specific chemical modification (a phosphorus group attached at one particular spot on the protein), compared to only about 5% of alpha-synuclein in healthy brains. But alpha-synuclein is just the main ingredient. Lewy bodies also contain over 100 additional proteins, lipid membranes, and fragments of cellular machinery, making them far more complex than a simple protein clump.
Alpha-Synuclein: The Primary Building Block
Alpha-synuclein is a small protein found abundantly in healthy nerve cells, where it helps regulate the release of chemical signals between neurons. In Lewy body diseases, this protein misfolds and sticks together into long, thread-like fibers called filaments, roughly 10 to 20 nanometers wide. These filaments pack tightly together and form the structural backbone of every Lewy body.
What triggers the misfolding isn’t fully understood, but the chemical modification appears to play a major role. In a healthy brain, only about 5% of alpha-synuclein is phosphorylated at a specific amino acid position (serine-129). Inside Lewy bodies, that figure jumps to roughly 90%. This modification likely accelerates the protein’s tendency to aggregate, or it may make the clumps more stable once they form. Pathologists use antibodies that detect this phosphorylated form of alpha-synuclein as the single best marker for identifying Lewy bodies in brain tissue after death.
The Three-Layer Structure
Under high-powered microscopes, Lewy bodies in the brainstem reveal a distinctive architecture: a dense central core surrounded by a pale outer halo. Detailed imaging with fluorescent antibodies has shown that this appearance reflects three concentric layers, each dominated by a different protein.
The innermost core is rich in ubiquitin, a small protein that cells normally use to tag damaged proteins for disposal. Surrounding that ubiquitin center is a thick layer of alpha-synuclein filaments. The outermost shell is composed of neurofilament, a structural protein that normally acts like scaffolding inside nerve cells. This layered arrangement suggests Lewy bodies aren’t random tangles. They form in an organized, stepwise process, with the cell’s waste-disposal machinery (ubiquitin) concentrated at the center and structural proteins accumulating around the outside.
Not all Lewy bodies look the same, though. In the brainstem, they tend to form round, well-defined spheres with that classic core-and-halo pattern. Cortical Lewy bodies, found in the outer layers of the brain, are more irregular in shape and rarely have a visible halo. The two types also differ in their minor protein content. Brainstem Lewy bodies contain enzymes involved in producing dopamine and acetylcholine concentrated in the core, while cortical versions have a different protein signature linked to the cell’s internal skeleton.
Over 100 Additional Proteins
Beyond the alpha-synuclein backbone, proteomic studies (which catalog every protein in a sample) have identified well over 100 distinct proteins within isolated Lewy bodies. A few show up consistently and are considered defining components alongside alpha-synuclein:
- Ubiquitin and phosphorylated ubiquitin reflect the cell’s failed attempts to break down the growing aggregate through its normal protein recycling system.
- p62/SQSTM1 is a protein that shuttles damaged material toward the cell’s internal recycling centers (a process called autophagy). Its presence signals that the cell recognized something was wrong but couldn’t clear it.
- Phosphorylated neurofilament subunits form the outer shell and point to disruption of the neuron’s internal transport system.
- Parkin, a protein linked to inherited forms of Parkinson’s disease, concentrates in the central domain of Lewy bodies alongside ubiquitin.
The sheer number of proteins found in Lewy bodies tells a story about what happens inside a struggling neuron. Many of these proteins belong to the cell’s quality-control systems, its protein-disposal pathways, or its internal structural framework. Their presence suggests that Lewy bodies aren’t just passive deposits. They form at the intersection of multiple failing cellular processes.
Lipids and Cellular Debris
For decades, researchers assumed Lewy bodies were purely protein aggregates. That view has shifted. Advanced microscopy techniques have revealed that many Lewy bodies also contain crowded organelles, lipid membranes, and membrane-bound vesicles tangled in with the protein fibers.
When scientists stain Lewy bodies with lipid-sensitive dyes, the signal overlaps heavily with the alpha-synuclein signal, indicating that fats and protein are intermingled throughout the structure. This makes biological sense: alpha-synuclein in its healthy form binds to cell membranes, so when it misfolds and aggregates, it likely drags membrane fragments along with it. Laboratory models show that alpha-synuclein-rich inclusions accumulate vesicles from the cell’s transport and recycling systems (endosomes, lysosomes, and Golgi-derived vesicles) while generally excluding flat membrane structures like the endoplasmic reticulum.
Mitochondria, the cell’s energy-producing structures, are sometimes found closely associated with the edges of Lewy bodies, though they don’t appear to be trapped inside the inclusions themselves. This proximity may reflect the well-documented relationship between alpha-synuclein toxicity and mitochondrial damage in Parkinson’s disease.
Why the Composition Matters
Knowing what Lewy bodies are made of has practical consequences. The discovery that alpha-synuclein filaments fold into disease-specific shapes has opened the door to new diagnostic tools. Using cryo-electron microscopy, researchers can now resolve the atomic structure of these filaments at resolutions around 3.3 angstroms. Different diseases produce filaments with distinct folds: Parkinson’s disease filaments look different from those in multiple system atrophy, another alpha-synuclein disorder. These structural differences are being used to develop blood and spinal fluid tests that can distinguish between diseases during a patient’s lifetime, rather than only at autopsy.
The complex mix of proteins, lipids, and organelles inside Lewy bodies also reshapes how scientists think about treatment. If Lewy bodies were simple protein clumps, dissolving the alpha-synuclein might be enough. But their composition suggests they represent a broader collapse of the neuron’s ability to manage its internal waste, maintain its structure, and keep its membranes organized. Effective therapies will likely need to address more than just the alpha-synuclein itself.